# Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19

> **NCT05305651** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 217 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Sotrovimab

## Key facts

- **NCT ID:** NCT05305651
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305651, "Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05305651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*